Passage BIO (PASG) Operating Leases (2022 - 2026)
Passage BIO (PASG) posted quarterly Operating Leases of $4.6 million for Q1 2026, down 78.55% year-over-year from $21.5 million in Q1 2025, and down 77.47% quarter-over-quarter from $20.4 million in Q4 2025.
Passage BIO (PASG) Operating Leases (2022 - 2026) Analysis & Trends
Passage BIO's Operating Leases history runs 5 years deep, the most recent figure standing at $4.6 million for Q1 2026.
- In Q1 2026, Operating Leases fell 78.55% year-over-year to $4.6 million; the TTM figure through Mar 2026 stood at $4.6 million (down 78.55% YoY), while the FY2025 annual figure was $20.4 million, down 6.17% from the prior year.
- Operating Leases for Q1 2026 stood at $4.6 million, down from $20.4 million in the prior quarter.
- The five-year high for Operating Leases was $24.4 million in Q1 2022, with the low at $4.6 million in Q1 2026.
- The 5-year median for Operating Leases is $22.8 million (2024), against an average of $21.6 million.
- The sharpest annual moves came in 2023 and 2026: Operating Leases dropped 3.2% in 2023, then plunged 78.55% in 2026.
- Passage BIO's Operating Leases stood at $23.8 million in 2022, then declined by 3.82% to $22.9 million in 2023, then retreated by 4.94% to $21.8 million in 2024, then slipped by 6.17% to $20.4 million in 2025, then slumped by 77.47% to $4.6 million in 2026.
- Business Quant data shows PASG's Operating Leases at $4.6 million in Q1 2026, $20.4 million in Q4 2025, and $20.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | Passage BIO | 13.99 Mn | 13.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.61 Mn |
| Dec 31, 2025 | 20.44 Mn |
| Sep 30, 2025 | 20.80 Mn |
| Jun 30, 2025 | 21.14 Mn |
| Mar 31, 2025 | 21.48 Mn |
| Dec 31, 2024 | 21.79 Mn |
| Sep 30, 2024 | 22.09 Mn |
| Jun 30, 2024 | 22.45 Mn |
| Mar 31, 2024 | 22.81 Mn |
| Dec 31, 2023 | 22.92 Mn |
| Sep 30, 2023 | 23.17 Mn |
| Jun 30, 2023 | 23.41 Mn |
| Mar 31, 2023 | 23.65 Mn |
| Dec 31, 2022 | 23.83 Mn |
| Sep 30, 2022 | 24.04 Mn |
| Jun 30, 2022 | 24.24 Mn |
| Mar 31, 2022 | 24.43 Mn |